glp-1 drug news today medications could cut US mortality by 6.4%, new study finds A wave of new #GLP1
Description
48 LiQ.JiaM.YanZ.LiQ.SunF.HeC.et al (2021)
If you are trying to lose weight and looking for a long-term solution with a low risk of adverse effects, working 1:1 with a personal dietitian can help

Thus, both GIP and GLP-1 agonists have independently proven themselves to be efficient in protecting the kidneys

[1] When patients take GLP-1 receptor agonists, healthcare providers typically monitor several blood parameters to assess treatment efficacy and safety, though none of these tests directly measure the GLP-1 medication itself
In both trials, major cardiovascular (MACE) events occurred equally in linagliptin-treated patients compared to those receiving other medications
Pharmaceutical supply chain expert, Dan Bell, Senior Vice President of Innovation & Strategic Operations at Marken, discusses the key challenges and considerations for GLP-1s
